Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 104 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Nothing Clear all

Conditions: Ventral Hernia
Interventions: Group 1; Device
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Asheville, North Carolina • Charlotte, North Carolina • Greenville, South Carolina

Conditions: Irritable Bowel Syndrome, Fibromyalgia
Interventions: Glutamate additive-free diet, Placebo diet; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Cigarette Smoking-Related Carcinoma
Interventions: Cigarette packaging, Data capture, Questionnaire administration; Other
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 21 Years to 69 Years
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Diabetes, Obesity
Interventions: Pre-study dietary and exercise instruction., Screening examination and oral glucose tolerance test, Euglycemic clamp, VO2max., Acute exercise bout, Percutaneous needle muscle biopsies; Behavioral · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 30 Years to 59 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: The Null Hypothesis is That Food Rheology Will Have no Effect on These Indices, The Alternate Hypothesis is That Increased Mechanical Stimulation Will Result in Stronger Satiation/Satiety and Reduced Energy Intake, It is Hypothesized That the Effects of Mastication Will be Less Evident in Obese Compared to Lean Individuals
Interventions: soft gum, firm gum, no gum; Other
Lead sponsor: Purdue University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: West Lafayette, Indiana

Conditions: Multiple Myeloma
Interventions: MAGE-A3, MAGE-A3 AND NY-ESO-1 IMMUNOTHERAPY; Biological
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 70 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2012
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Diabetes Mellitus
Interventions: Dexamethasone, No dexamethasone; Drug · Other
Lead sponsor: Ascension Health; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Grand Blanc, Michigan

Conditions: Value of the Bowel Preparation and Diet Change Versus no Intervention, Preoperative Bowel Regimen
Interventions: No bowel prep, Clear liquid diet and 2 Fleet's enemas; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Spatial Audio Stimulation
Interventions: Spatial audio stimulation, No spatial audio stimulation; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 99 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Mouth Abnormalities, Cleft Palate, Birth Defect
Interventions: Ropivacaine, Sham Comparator; Drug · Other
Lead sponsor: University of Florida; Other
Eligibility: 3 Months to 5 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Epilepsy
Interventions: HealthBuddy; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 6 Months to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Type 1 Diabetes
Interventions: Financial incentive (gain), Financial incentive (loss); Behavioral
Lead sponsor: Harvard Pilgrim Health Care; Other
Eligibility: 12 Years to 18 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Labor, Induced, Cervix Uteri-Diseases
Interventions: Outpatient Dilapan-S, Inpatient Dilapan-S; Device
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 338 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: New York, New York • Galveston, Texas

Conditions: Pancreatic Adenocarcinoma
Interventions: MRIs with and without intravenous contrast (up to 2); Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes Mellitus
Interventions: NPH, Correction Factor; Drug
Lead sponsor: Hennepin Healthcare Research Institute; Other
Eligibility: 18 Years to 79 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Nonalcoholic Fatty Liver Disease (NAFLD)
Interventions: intravenous fructose challenge, Blood Draw; Drug · Other
Lead sponsor: Manal F Abdelmalek; Other
Eligibility: 18 Years to 75 Years
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pain, Anxiety
Interventions: Hand-holding, Stress Ball; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 135 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Upper Extremity Paresis, Disability Physical, Chronic Stroke, Motor Disorders
Interventions: Somatosensory Electrical Stimulation; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 80 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Jellyfish Stings
Interventions: Acetic Acid (5%), Sodium Bicarbonate Slurry (50%), Papain Slurry (70%), Ammonia (10%), Lidocaine (4%), Isopropyl Alcohol (70%), Hot Tap Water (40 degrees Celsius), No treatment; Other · Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: PreDiabetes
Interventions: NDPP-Flex, NDPP; Behavioral
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Multiple Sclerosis
Interventions: Cognitive Training; Other
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Leukemia
Interventions: gemtuzumab ozogamicin, observation, Cytosine arabinoside, Daunomycin; Drug · Other
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years to 60 Years
Enrollment: 637 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 255
States / cities: Anchorage, Alaska • Fort Smith, Arkansas • Little Rock, Arkansas + 161 more

Conditions: Vaping
Interventions: Financial reward graphic message, Health reward graphic message, Self-efficacy graphic message, Social norms graphic message; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 12 Years to 17 Years
Enrollment: 362 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Community Dwelling Adults Aged 50 and Older
Interventions: Pilot Resilience Building Intervention; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 50 Years and older
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Birmingham, Alabama

Search by objective public record fields.

Microlyte in Prevention of SSI After Open Ventral Hernia Repair

Clinical Trial Examining Effects of Monosodium Glutamate (MSG) on Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM)

Effects of Filter Ventilation and Ventilation Information on Product Use Behaviors in Cigarette Smokers

PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes

Effects of Gum Chewing on Appetite and Digestion

Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma

Intraoperative Dexamethasone and Its Effect on Hyperglycemia

Patient Experience and Bowel Preparation for Transvaginal Surgical Management of Vaginal Prolapse

NOICE vs. Nothing | Thermode

Evaluation of Trigeminal Nerve Blockade

Remote Tracking of Epilepsy Patients

Promoting Adolescent Investment In Diabetes Care

Comparing Outpatient to Inpatient Cervical Ripening Using Dilapan-S®

Prospective Evaluation of MRI Biomarkers in Pancreatic Ductal Adenocarcinoma

Inpatient Diabetes on Corticosteroids

Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver Disease

Patient Comfort During Dermatologic Procedures

Hand Rehabilitation Study for Stroke Patients

Effective Treatments for Jellyfish Stings

Patient-centered Goal Setting in the National Diabetes Prevention Program

Computerized Cognition Testing and Cognitive Motor Interference in MS

S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML

Graphic Messages to Prevent E-Cigarette Use Among Black and Latino Adolescents

A Resilience Building Intervention to Promote Successful Aging